The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles

Saudi Medical Journal

Volumn 26, Issue 10, 2005, Pages 1584-1587

  Owj, Monir ^a   Tehrani Nejad, Ensieh S ^a   Amirchaghmaghi, Elham ^a   Baghestani, Ahamd R ^a   Ahmadi, Jila ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; ESTROGEN; HUMAN MENOPAUSAL GONADOTROPIN; KETOCONAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; IRAN; MAJOR CLINICAL STUDY; OVARY DISEASE; OVARY FOLLICLE CELL; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; RANDOMIZED CONTROLLED TRIAL; REPRODUCTIVE PROCEDURES; SIDE EFFECT; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEROIDOGENESIS;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILIZATION IN VITRO; FOLLOW-UP STUDIES; HUMANS; KETOCONAZOLE; MATERNAL AGE; OVARIAN HYPERSTIMULATION SYNDROME; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PROBABILITY; REFERENCE VALUES; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 29144473653     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rizk B, Smitz J. Ovarian hyperstimulation syndrome after super ovulation for IVF and related procedures. Hum Reprod 1999; 7: 320-327.
2. MacDougall MJ, Tan SL, Balen A, Jacobs HS. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 1993; 8: 233-237.
3. Buvat J, Buvat Herbaut M, Marcolin G, Dehaence JL, Verbeeq P, Renouard O. Purified follicle stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective. Fertil Steril 1989; 52: 553-559.
4. Ron EL-R. Complications of ovulation induction. Baillieres Clin Obstet Gynecol 1993; 7: 735-753.
5. Egbase PE, Makhseed M, Al-Sharhan M, GrudZinskas JG. Timed unilateral ovarian follicular aspiration prior to administration of human chorionic gonadotrophin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization: a prospective randomized study. Hum Reprod 1997; 12: 2603-2606.
6. Chian RC, Buckett W, Too L, Tan SL. Pregnancies resulting from in vitro matured oocytes retrieved from patients with polycystic ovary syndrome after priming with human chorionic gonadotropin. Fertil Steril 1999; 72: 639-642.
7. Smith EB, Henry JC. Ketoconazole: an orally effective antifungal agent. Mechanism of action, pharmacology, clinical efficacy and adverse effects. Pharmacotherapy 1984; 4: 199-204.
8. Weber MM, Will A, Adelmann B, Engelhardt D. Effect of ketoconazole on human ovarian C17, 20-desmolase and aromatase. J Steroid Biochem Mol Biol 1991; 38: 213-218.
9. Gal M, Orly J, Barr I, Algur N, Boldes R, Diaman TYZ. Low dose ketoconazole attenuates serum androgen levels in patients with polycystic ovary syndrome and inhibits ovarian steroidogenesis in vitro. Fertil Steril 1994; 61: 823-832.
10. Pepper G, Brenner SH, Gabrilover JL. Ketoconazol use in the treatment of ovarian hyperandrogenism. Fertil Steril 1990; 54: 438-444.
11. Gal M, Eldar Geva T, Margalioth EJ, Barr I, Orly J, Diamanty Z. Attenuation of ovarian response by low dose ketoconazole during superovulation in patients with polycystic ovary syndrome. Fertil Steril 1999; 72: 26-31.
12. Parsanezhad ME, Alborzi S, Pakniat M, Schmidt EH. A double blind, randomized, placebo controlled study to assess the efficacy of Ketoconazole for reducing the risk of ovarian hyperstimulation syndrome. Fertil Steril 2003; 80: 1151-1155.
13. Homburg R, Neiman E. Polycystic Ovary Syndrome United Kingdom: Martin Dunitz; 2001.
14. Golan A, Ron EL-R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989; 44: 430-440.
15. Engelhardt D, Weber MM. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors. J Steroid Biochem Mol Biol 1994; 49: 261-267.
16. Mahler C, Verhelst J, Denis L. Ketoconazole and Liarozole in the treatment of advanced prostatic cancer. Cancer 1993; 71: 1068-1073.
17. Zelinski-Wooten MB, Hess DL, Wolf DP, Stouffer RL. Steroid reduction during ovarian stimulation impairs oocyte fertilization, but not folliculogenesis, in rhesus monkeys. Fertil Steril 1994; 61: 1147-1155.